Hill’s launches feline therapeutic diet for weight and mobility: full analysis

Hill’s Pet Nutrition is adding a new option to the feline therapeutic nutrition market with the launch of Prescription Diet Metabolic + j/d, a prescription diet designed to support both weight loss and mobility in cats. Announced April 30, the product is being positioned for cats that are overweight and also showing mobility concerns, a combination many veterinary teams see regularly in practice. Hill’s says the formula is available through veterinary recommendation. (prnewswire.com)

The launch builds on two established Hill’s therapeutic diet lines: Metabolic, aimed at weight management, and j/d, aimed at joint care. According to the company and trade coverage, the new product brings those platforms together in one formula rather than asking clinicians and pet parents to prioritize one problem over the other. That matters because excess weight can worsen comfort and function in cats with joint disease, even as feline osteoarthritis itself remains easy to miss when signs show up as behavioral changes, reduced jumping, altered grooming, or lower activity rather than obvious lameness. (dvm360.com)

Hill’s says the diet uses a targeted blend of omega-3 fatty acids to support joint health and reduce inflammation, along with nutrients intended to nourish cartilage. On the weight side, the company says the formula is designed to activate metabolism, support fat burning, and help cats feel full and satisfied through its fiber blend. On Hill’s product page, the food is described as complete and balanced for maintenance of adult cats under AAFCO feeding-test standards, and the company says the diet is clinically shown to improve cats’ ability to run, jump, and play in as little as one month. Hill’s also cites prior Metabolic data showing 88% of pets lost weight in two months at home when fed Metabolic nutrition alone, though that claim is not specific to this newly combined feline formula. (prnewswire.com)

So far, the public evidence base tied directly to the launch appears to be company-led messaging rather than a newly published peer-reviewed study on the combined feline diet. That doesn’t make the product unimportant, but it does mean veterinarians may want to distinguish between evidence supporting the legacy Metabolic and j/d platforms and evidence specific to this new combination formula. In other words, the clinical rationale is plausible and aligned with current management principles, but broader adoption may depend on whether Hill’s releases more detailed feline trial data, conference abstracts, or publication results. This is an inference based on the launch materials and currently available public sources. (prnewswire.com)

Company executives framed the launch as a quality-of-life tool for veterinarians and pet parents. In the press release, Chelsie Estey, DVM, DACVIM, Hill’s U.S. chief veterinary officer, said the company is focused on giving veterinarians better tools for patient care, while marketing executive Carrick Massey said the new offering is meant to support veterinarians, pet parents, and cats together. Independent expert commentary specific to this launch was limited in publicly available coverage at the time of writing, but broader veterinary guidance supports the underlying clinical focus: obesity is prevalent, and weight reduction is commonly recommended as part of managing OA-related discomfort in overweight cats. (prnewswire.com)

Why it matters: For veterinary professionals, this is less about a single product debut and more about where therapeutic nutrition is heading. Cats often present with overlapping chronic conditions, and pet parents may struggle with complex feeding plans or multiple therapeutic goals. A combined diet could make conversations easier in the exam room, especially when a clinician is trying to connect body condition, mobility, pain, activity, and long-term quality of life. It may also help practices frame nutrition as an active intervention rather than a secondary add-on to medication or environmental modification. (dvm360.com)

There’s also a business and workflow angle. Prescription diets that address comorbidities can support continuity of care, reinforce the veterinarian-client relationship, and potentially improve compliance when compared with more fragmented management plans. At the same time, teams will need to set expectations carefully: mobility changes in cats are multifactorial, OA diagnosis can be challenging, and nutrition alone won’t replace a full diagnostic workup or multimodal pain plan where indicated. (dvm360.com)

What to watch: The next key developments will be whether Hill’s publishes feline-specific clinical data on the combined formula, how distributors and clinics position the product in practice, and whether it becomes part of standard protocols for overweight cats with suspected OA or reduced mobility over the rest of 2026. (prnewswire.com)